The first stop for professional medicines advice

COVID-19 Vaccines

Information and guidance from across SPS on pharmaceutical aspects of COVID-19 vaccines’ use

General information and guidance

Pfizer-BioNTech

AstraZeneca

Moderna

Most recent in "General information and guidance: Answers to Questions"

Using COVID-19 vaccines appropriately in temporary vaccination sites
In temporary vaccination sites, good medicines governance will ensure safe and secure handling. Key issues are listed and implementation tools are provided.
All vaccines: Handling in temporary vaccination sites22 March 2021
Dosing information for COVID-19 Vaccines
Guidance on dosing for all available COVID-19 vaccines - reference to the vaccine specific pages provides supplementary information
All vaccines: Answers to Questions25 February 2021
Preparing and administering COVID-19 Vaccines
Guidance on preparing and administering common to all available COVID-19 vaccines, and specific to individual vaccines
All vaccines: Answers to Questions11 February 2021
Suitability for COVID-19 vaccination based on prior allergy or current dietary practices
Prior allergy and religious or other dietary requirements could occasionally affect suitability for vaccination, and patients will often have questions.
All vaccines: Answers to Questions3 February 2021
Search Most recent in "General information and guidance: Answers to Questions"

Most recent in "Pfizer-BioNTech: Answers to Questions"

Using COVID-19 Vaccine Pfizer-BioNTech appropriately in temporary vaccination sites
Advice on appropriately transporting, storing, preparing and administering COVID-19 Vaccine Pfizer-BioNTech. Assumes the vaccine is received thawed.
Pfizer-BioNTech Vaccine: Answers to Questions22 March 2021
Preparing and administering the Pfizer-BioNTech COVID-19 Vaccine
Preparing vaccine using our SOPs, plus additional advice on diluent use, batch numbers, withdrawing additional doses and post-vaccination observation
Pfizer-BioNTech Vaccine: Answers to Questions27 January 2021
Defrosting the Pfizer-BioNTech COVID-19 vaccine
The Pfizer-BioNTech COVID-19 vaccine must be defrosted before use. This page gives guidance on considerations whilst thawing the vaccine.
Pfizer-BioNTech Vaccine: Answers to Questions25 January 2021
Dosing information for Pfizer-BioNTech COVID-19 Vaccine
Information on intervals between dosing and completion of the vaccination schedule where an alternative brand of vaccine is given.
Pfizer-BioNTech Vaccine: Answers to Questions7 January 2021
Search Most recent in "Pfizer-BioNTech: Answers to Questions"

Most recent in "AstraZeneca: Answers to Questions"

COVID-19 vaccination and blood clotting
A summary of MHRA and JCVI guidance on use of AstraZeneca COVID-19 vaccine in age specific groups
AstraZeneca Vaccine: Answers to Questions9 April 2021
Using COVID-19 Vaccine AstraZeneca appropriately in temporary vaccination sites
Advice on appropriately transporting, storing, preparing and administering COVID-19 Vaccine AstraZeneca for a "drive-through" model.
AstraZeneca Vaccine: Answers to Questions18 March 2021
Preparing and administering the AstraZeneca COVID-19 Vaccine
Preparing vaccine using our SOPs, plus additional advice on batch numbers, withdrawing additional doses and post-vaccination observation
AstraZeneca Vaccine: Answers to Questions27 January 2021
Dosing information for AstraZeneca COVID-19 Vaccine
Information on intervals between dosing and completion of the vaccination schedule with an alternative brand of vaccine is given.
AstraZeneca Vaccine: Answers to Questions13 January 2021
Search Most recent in "AstraZeneca: Answers to Questions"